Skip to main content

Want a detailed portfolio tracker?

Agenus (AGEN) P/E (2012 - 2026)

Agenus (AGEN) P/E from Apr 2, 2012 to Jun 3, 2026. The TTM Agenus (AGEN) P/E is 3.16. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Agenus (AGEN)

YearP/EChange
20263.16-130.26%
2025-10.45+655.58%
2024-1.38-93.63%
2023-21.73-64.85%
2022-61.81-25.47%
2021-82.93+1.26%
2020-81.90-21.87%
2019-104.82+71.01%
2018-61.29-26.99%
2017-83.96-20.87%
2016-106.10-9.25%
2015-116.92+14.36%
2014-102.24+50.38%
2013-67.99-183.79%
201281.14N/A

Comparison Agenus (AGEN) P/E with competitors

Agenus (AGEN) P/E is 3.16.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.95%
NBYStablecoin Development Corp0.10-96.77%
ENLVEnlivex Therapeutics Ltd0.15-95.25%
FGENFibroGen Inc0.24-92.41%
TRAWTraws Pharma Inc0.47-85.05%
FBIOFortress Biotech Inc0.71-77.68%
CHRSCoherus Biosciences Inc0.98-69.08%
ORMPOramed Pharmaceuticals Inc1.47-53.42%
VIVSVivoSim Labs Inc2.54-19.84%
INVAInnoviva Inc3.19+0.79%
CRMDCorMedix Inc3.65+15.24%
ABEOAbeona Therapeutics Inc4.20+32.92%
VXRTVaxart Inc4.26+34.71%
CVACCureVac N.V.4.45+40.53%
SRPTSarepta Therapeutics Inc4.62+46.17%
GLPGGalapagos NV4.86+53.59%
RIGLRigel Pharmaceuticals4.92+55.51%
ZVRAZevra Therapeutics Inc4.97+57.23%
ABUSArbutus Biopharma Corp5.69+79.98%
CGENCompugen Ltd7.38+133.41%
AUPHAurinia Pharmaceuticals Inc9.25+192.44%
ACADAcadia Pharmaceuticals Inc9.59+203.08%
OMEROmeros Corporation9.88+212.42%
PLXProtalix BioTherapeutics Inc9.91+213.23%
SPROSpero Therapeutics Inc10.73+239.33%
ADMAAdma Biologics Inc11.33+258.17%
SVASinovac Biotech Ltd11.44+261.50%
TBPHTheravance Biopharma Inc11.78+272.26%
HRMYHarmony Biosciences Holdings Inc12.18+285.03%
TGTXTG Therapeutics Inc13.18+316.61%
INCYIncyte Corp13.38+323.01%
SABSSAB Biotherapeutics Inc14.06+344.37%
XOMAXOMA Corp14.95+372.43%
REGNRegeneron Pharmaceuticals Inc14.98+373.53%
PBYIPuma Biotechnology Inc15.05+375.75%
EXELExelixis Inc15.79+399.28%
NAGENiagen Bioscience Inc16.35+416.99%
CPRXCatalyst Pharmaceuticals Inc17.34+448.28%
MDXGMimedx Group Inc17.38+449.24%
ARGXArgen X SE23.07+629.30%
HALOHalozyme Therapeutics Inc23.20+633.38%
XOMAOXOMA Corp25.34+701.16%
VRTXVertex Pharmaceuticals Inc25.66+710.99%
XOMAPXOMA Corp25.67+711.44%
CTMXCytomX Therapeutics Inc25.70+712.32%
ASNDAscendis Pharma A/S26.35+733.07%
RPRXRoyalty Pharma plc - Class A27.50+769.14%
SLNOSoleno Therapeutics Inc29.02+817.19%
LGNDLigand Pharmaceuticals Inc - Class B30.19+854.21%
BMRNBiomarin Pharmaceutical Inc37.51+1085.62%
APLSApellis Pharmaceuticals Inc39.02+1133.48%
KRYSKrystal Biotech Inc39.70+1154.86%
GMABGenmab40.20+1170.86%
ONCBeiGene Ltd67.03+2018.76%
TECHBio-Techne Corp68.59+2068.33%
VCELVericel Corp80.63+2448.73%
PHARPharming Group N.V.87.74+2673.51%
ALNYAlnylam Pharmaceuticals Inc124.93+3849.22%
TLXTelix Pharmaceuticals Ltd139.89+4322.02%
CORTCorcept Therapeutics Inc158.39+4906.77%